Through the story of Rub√©n and his acid-peptic disorder processes are illustrated that permit the development and approval of new medicines by the pharmaceutical industry and health officials today. The co-responsible participation of patients in their treatment is discussed as well as the pitfalls or obstacles they may face on the path toward successfully implementing regimens that improve their quality of life.